X hits on this document

Word document

Parkinson’s Disease Bibliography. Oct 2010. - page 2 / 6





2 / 6

(13) Leegwater-Kim J, Bortan E. The role of rasagiline in the treatment of Parkinson's disease. Clinical Interventions In Aging 2010; 5:149-156.

(14) Mehnert S, Reuter I, Schepp K, Maaser P, Stolz E, Kaps M. Transcranial sonography for diagnosis of Parkinson's disease. BMC Neurology 2010; 10.

(15) Mehrholz J, Friis R, Kugler J, Twork S, Storch A, Pohl M. Treadmill training for patients with Parkinson's disease. Mehrholz Jan , Friis Robert , Kugler Joachim , Twork Sabine , Storch Alexander , Pohl Marcus Treadmill training for patients with Parkinson's disease Cochrane Database of Systematic Reviews: Reviews 2010 Issue 1 John Wiley & Sons , Ltd Chichester, UK DO 2010.

(16) Mertens B, Vanderheyden P, Michotte Y, Sarre S. The role of the central renin-angiotensin system in Parkinson's disease. Journal of the Renin-Angiotensin-Aldosterone System 2010; 11(1):49-56.

(17) Muller T, Muhlack S. Effect of exercise on reactivity and motor behaviour in patients with Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 2010; 81(7):747-753.

(18) Postuma RB, Gagnon JF, Montplaisir J. Clinical prediction of Parkinson's disease: planning for the age of neuroprotection. Journal of Neurology, Neurosurgery & Psychiatry 2010; 81(9):1008-1013.

(19) Pradhan SD, Brewer BR, Carvell GE, Sparto PJ, Delitto A, Matsuoka Y. Assessment of fine motor control in individuals with Parkinson's disease using force tracking with a secondary cognitive task. Journal of Neurologic Physical Therapy 2010; 34(1):32-40.

(20) Rodriguez-Oroz MC. Deep brain stimulation for advanced Parkinson's disease. Lancet Neurology 2010; 9(6):558-559.

(21) Simon DK, Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A et al. Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease. BMC Medical Genetics 2010; 11:53

(22) Sixel-Doring F, Trenkwalder C, Kappus C, Hellwig D. Skin complications in deep brain stimulation for Parkinson's disease: frequency, time course, and risk factors. Acta Neurochirurgica 2010; 152(2):195-200.

(23) Stowe R, Ives N, Clarke CE, Deane K, van H, Wheatley K et al. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson’s disease patients with motor complications. Cochrane Database Syst Rev. 2010. Jul 7.

(24) Takahashi K, Tickle-Degnen L, Coster WJ, Latham NK. Expressive behavior in Parkinson's disease as a function of interview context. American Journal of Occupational Therapy 2010; 64(3):484-495.

(25) Viscomi P, Jeffrey J. Development of clinical practice guidelines for patient management of blood pressure instability in multiple system atrophy, Parkinson's disease, and other neurological disorders. Canadian Journal of Neuroscience Nursing 2010; 32(2):6-19.


Document info
Document views26
Page views27
Page last viewedTue Jan 17 13:51:18 UTC 2017